US8496826B2ExpiredUtilityA1

Body fluid treating device of hollow fiber membrane type

45
Assignee: UCHI YUKIHIKOPriority: Apr 23, 2003Filed: Apr 23, 2004Granted: Jul 30, 2013
Est. expiryApr 23, 2023(expired)· nominal 20-yr term from priority
B01D 2313/205B01D 63/021B01D 63/02A61M 2202/0498A61M 1/16A61M 2205/15B01D 2313/14B01D 63/024B01D 65/104
45
PatentIndex Score
6
Cited by
31
References
5
Claims

Abstract

A hollow fiber membrane type fluid treatment device having at least a body portion of tubular housing containing a hollow fiber membrane bundle. In the hollow fiber membrane type fluid treatment device, an inner surface of a body portion of the tubular housing at a side of a treatment liquid inlet has a body straight portion and an end tapered portion which increases in diameter toward an end face of the housing body portion, the hollow fiber membrane is arranged so that a distance between the hollow fiber membranes is gradually increased toward the end face on the treatment liquid inlet side along a taper of a tapered portion of the inner surface of the housing body portion, and a liquid to be treated flows within the hollow fiber membranes and a treatment liquid flows outside of the hollow fiber membranes.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A hollow fiber membrane type fluid treatment device for treating blood, the fluid treatment device comprising:
 a housing body portion of a tubular housing containing a single hollow fiber membrane bundle; 
 a first housing head portion which is connected with one end of the housing body portion and has a resin layer where the hollow fiber membrane bundle is fixed by using a resin composition, and a first connection port which serves as a treatment liquid inlet; 
 a second housing head portion which is connected with a second end of the housing body portion and has a resin layer where the hollow fiber membrane bundle is fixed by using a resin composition, and a second connection port which serves as a treatment liquid outlet; 
 first and second header caps attached to the first and second housing head portions, respectively, and the first and second header caps having respective treatment target liquid connection ports; and 
 an inner surface of the housing body portion comprises a body straight portion in a center of the housing body portion and an end tapered portion provided at opposing ends of the housing body portion, the end tapered portion increasing in diameter toward an end face of the housing body portion, and hollow fiber membranes of the hollow fiber membrane bundle are arranged so that a distance between individual hollow fiber membranes is gradually increased toward the end face of the housing body portion as the hollow fiber membranes extend along a taper of the end tapered portion, thereby increasing the diameter of the hollow fiber membrane bundle, 
 opening ends of the hollow fiber membrane bundle being fixed to an inside of the tubular housing by the resin layers, and the opening ends of the hollow fiber membrane bundle facing the respective treatment target liquid connection ports such that blood flows within the hollow fiber membranes, 
 the treatment liquid inlet and treatment liquid outlet being provided at a circumference of the hollow fiber membrane bundle such that a treatment liquid flows outside of the hollow fiber membranes, the hollow fiber membrane bundle configured to allow waste in the blood to be removed through dialysis utilizing one of a diffusion phenomenon resulting from a concentration gradient and filtration resulting from a pressure gradient, 
 wherein an angle formed by a centerline of the inner surface of the housing body portion and an inner surface of the end tapered portion is greater than 0° and smaller than an angle defined by tan −1  {1/2·(d 1 -d 4 )/L 4 } (where, d 1  is the diameter of the hollow fiber membrane bundle at an end face of the resin layer, d 4  is an inner diameter of the body straight portion or minimum diameter portion of the housing body portion, and L 4  is the length (one side) of the end tapered portion which increases in diameter toward the end face of the housing body portion), and 
 wherein a ratio of the length of the body straight portion to the total length of the end tapered portion is 0.7 to 20, and a ratio of the inner diameter of the end tapered portion at the end face of the housing body portion to the inner diameter of the body straight portion is more than 1 and not more than 3. 
 
     
     
       2. The hollow fiber membrane type fluid treatment device according to  claim 1 , wherein the tapered portion comprises a first tapered portion located on the body portion side, and a second tapered portion located on the treatment liquid inlet side, and the angle of the first taper angle is smaller than the angle of the second taper angle. 
     
     
       3. The hollow fiber membrane type fluid treatment device according to  claim 1 , having a urea clearance and a vitamin B12 clearance of 191 to 200 ml/min and 135 to 170 ml/min, respectively. 
     
     
       4. The hollow fiber membrane type fluid treatment device according to  claim 1 , comprising baffle plates provided at positions corresponding to the treatment liquid inlet and the treatment liquid outlet of the tubular housing and interspatially from the inner circumference of the tubular housing over the entire inner circumference at a curvature almost along the inner circumference. 
     
     
       5. The hollow fiber membrane type fluid treatment device according to  claim 4 , wherein the baffle plate gradually increases in diameter toward the end face of the housing.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.